Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep1191 | Steroid metabolism + action | ECE2017

Non-alcoholic fatty liver disease and its relation with sex steroids in men

Van de Velde Frederique , Van Nieuwenhove Yves , Bekaert Marlies , Hoorens Anne , Praet Marleen , Kaufman Jean-Marc , Lapauw Bruno

Background: Obesity associates with co-morbidities as non-alcoholic fatty liver disease (NAFLD). Obese men often present with low testosterone (T) levels. As sex steroids undergo hepatic metabolization and their serum levels depend on hepatic sex hormone binding globulin (SHBG) secretion, NAFLD could contribute to this phenomenon. Previous studies however were contradictory and not based on state-of-the-art technology as mass spectrometry or biopsy-proven NAFLD.<p class="a...

ea0057022 | Non-alcoholic fatty liver disease and its association with insulin resistance in an obese population | BES2018

Non-alcoholic fatty liver disease and its association with insulin resistance in an obese population

Frederique Van de Velde , Marlies Bekaert , Anne Hoorens , Marleen Praet , Arsene-Helene Batens , Shadid S , Yves Van Nieuwenhove , Bruno Lapauw

Background: Obesity induced inflammation is a key component in the pathogenesis of insulin resistance (IR). In addition, obesity-related non-alcoholic fatty liver disease (NAFLD) also seems to contribute to IR development. Until now, however, it is unclear which, if any component of NAFLD specifically associates with IR. Therefore, the aim is to assess if individual components of NAFLD contribute to IR in obese patients undergoing gastric bypass surgery (GBS).<p class="abs...

ea0056p531 | Obesity | ECE2018

Non-alcoholic fatty liver disease and its association with insulin resistance in an obese population

Velde Frederique Van de , Bekaert Marlies , Hoorens Anne , Praet Marleen , Batens Arsene-Helene , Shadid Samyah , Nieuwenhove Yves Van , Lapauw Bruno

Background and aims: Obesity induced inflammation is a key component in the pathogenesis of insulin resistance (IR). In addition, obesity-related non-alcoholic fatty liver disease (NAFLD) also seems to contribute to IR development. Until now, however, it is unclear which, if any component of NAFLD specifically associates with IR. Therefore, the aim is to assess if individual components of NAFLD contribute to IR in obese patients undergoing gastric bypass surgery (GBS).<p c...